The impact of host and tumor derived IL-1 on tumor growth and host defense

Number of publications: 4
Israeli Partner: R. Apte, Ben-Gurion Univ.
German Partner: M. Zoeller, DKFZ

Publications

Publication
Publication
Elkabets, M., Krelin, Y., Dotan, S., Cerwenka, A., Porgador, A., Lichtenstein, R. G., White, M. R., Zoller, M., Iwakura, Y., Dinarello, C. A., Voronov, E., Apte, R. N.

Host-derived interleukin-1alpha is important in determining the immunogenicity of 3-methylcholantrene tumor cells 182 (8), J Immunol, 4874-81, 2009

Marhaba, R., Nazarenko, I., Knofler, D., Reich, E., Voronov, E., Vitacolonna, M., Hildebrand, D., Elter, E., Apte, R. N., Zoller, M.

Opposing effects of fibrosarcoma cell-derived IL-1 alpha and IL-1 beta on immune response induction 123 (1), Int J Cancer, 134-45, 2008

Nazarenko, I., Marhaba, R., Reich, E., Voronov, E., Vitacolonna, M., Hildebrand, D., Elter, E., Rajasagi, M., Apte, R. N., Zoller, M.

Tumorigenicity of IL-1alpha- and IL-1beta-deficient fibrosarcoma cells 10 (6), Neoplasia, 549-62, 2008

Weiss, T., Vitacolonna, M., Zoller, M.

The efficacy of an IL-1alpha vaccine depends on IL-1RI availability and concomitant myeloid-derived suppressor cell reduction 32 (6), J Immunother, 552-64, 2009

to top